Matches in Nanopublications for { ?s ?p "[CCND1 gene amplification was observed in 8.7% and RSF1 in 6.8% of these patients, preferentially in estrogen receptor-positive breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[CCND1 gene amplification was observed in 8.7% and RSF1 in 6.8% of these patients, preferentially in estrogen receptor-positive breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[CCND1 gene amplification was observed in 8.7% and RSF1 in 6.8% of these patients, preferentially in estrogen receptor-positive breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP908604.RAV6kd-Pv9VJSNjf6whwbzsltvpc0U1tjVpCy9Cyc3Cf8130_assertion description "[CCND1 gene amplification was observed in 8.7% and RSF1 in 6.8% of these patients, preferentially in estrogen receptor-positive breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP908604.RAV6kd-Pv9VJSNjf6whwbzsltvpc0U1tjVpCy9Cyc3Cf8130_provenance.
- NP1139545.RA02v5tU3AV6Qmk1qObsLwKF0ntO2wiAKBz4W_KKD-V-o130_assertion description "[CCND1 gene amplification was observed in 8.7% and RSF1 in 6.8% of these patients, preferentially in estrogen receptor-positive breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1139545.RA02v5tU3AV6Qmk1qObsLwKF0ntO2wiAKBz4W_KKD-V-o130_provenance.
- NP1139547.RAaum66-6ziaucbms49fsVu3e46HRZWRfI4ThaAuuk46U130_assertion description "[CCND1 gene amplification was observed in 8.7% and RSF1 in 6.8% of these patients, preferentially in estrogen receptor-positive breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1139547.RAaum66-6ziaucbms49fsVu3e46HRZWRfI4ThaAuuk46U130_provenance.
- assertion description "[CCND1 gene amplification was observed in 8.7% and RSF1 in 6.8% of these patients, preferentially in estrogen receptor-positive breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.